The new indication, which the Food and Drug Administration announced on Friday, will pave the way for even more patients to use the sought-after medication and could potentially broaden insurance coverage.
Among those who received placebo shots, 8 percent had a heart attack, stroke, or died from a cardiovascular event, compared with 6.5 percent of participants who took Wegovy.
[
add
]
[
|
|
...
]